Thursday, March 31, 2011

Allergan Gastric Band: Europe Questions Long Term Benefits

It's a worldwide phenom!
Pharma giant Allergan is under attack in Europe concerning a new weight loss device to hit the market full force, the Lap-Band System. This system was recently U.S. FDA approved for those with a lower body mass index (BMI) than ever before, but is catching some flack in European studies.

A new study has questioned the long-term effectiveness of the popular Lap-Band weight-loss device, finding that many patients suffered major complications and half of them eventually had the device removed.
Bad device news travels fast.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.